Results 151 to 160 of about 82,508 (316)
ABSTRACT Aim To analyse the effect of systemic amoxicillin and metronidazole on surgical peri‐implantitis treatment with a follow‐up period of 1 year. Materials and Methods Fifty‐nine patients were randomly assigned to receive peri‐implantitis surgery supplemented with (29 patients; test) or without (30 patients; control) systemic amoxicillin and ...
Jarno Hakkers +4 more
wiley +1 more source
CASE 2. Osteonecrosis of the Jaws Associated With Bisphosphonate Therapy [PDF]
Michele Davide Mignogna +4 more
openalex +1 more source
Review of: "Bisphosphonate-Related Osteonecrosis of the Jaws Treated with Platelet-Rich Plasma: Preliminary Results from a Case Series" [PDF]
Raíssa Dias Fares
openalex +1 more source
DXA Utilization Among Veterans Aged ≥ 50 years by Facility‐Reported DXA Capacity.
Heather Davila +6 more
wiley +1 more source
Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report [PDF]
Do-Sup Kim +6 more
openalex +1 more source
Use of bisphosphonates in experimental bone tuberculous osteitis: CT imaging
Veronika V. Petukhova +6 more
openalex +1 more source
ABSTRACT Background The impact of vitamin D on fall incidence remains controversial. We studied the effect of 5 years of vitamin D3 supplementation on the risk of falls in a double‐blind, placebo‐controlled randomized trial with generally healthy, community‐dwelling men and women in Finland.
Toni Rikkonen +9 more
wiley +1 more source
AGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012 [PDF]
Harbeck, Nadia +2 more
core +2 more sources
Bisphosphonates for the prevention of osteoporotic fractures in postmenopausal women with osteopenia: a systematic review and meta-analysis [PDF]
S. V. Yureneva, V. G. Averkova
openalex +1 more source
ABSTRACT Objectives This study presents a trend analysis of Medication‐Related Osteonecrosis of the Jaw (MRONJ) using US National Inpatient Sample (NIS) data from 2016 to 2022, providing insights into its epidemiology, comorbidities, and economics.
N. Sheshashayee +3 more
wiley +1 more source

